TL;DR
- •Physicians have one of the highest occupational suicide rates of any profession — recent meta-analyses (Zimmermann 2024) find male physician suicide rates comparable to the general male population but female physician rates roughly 1.5x higher than non-physician women, while depression prevalence in residents has been documented around 28%.
- •Training trauma, perfectionism culture, EHR burnout, malpractice anxiety, and the gap between aspirational and actual clinical care produce a specific stressor profile that's distinct from other high-stress professions.
- •State medical board reporting concerns and FSPHP (Federation of State Physician Health Programs) involvement are real but often misunderstood — most states only require disclosure of conditions that impair practice, not the existence of treatment itself.
- •Telehealth ketamine therapy fits the physician schedule — sessions evenings or weekends, no clinic visits where colleagues might see you, completely private from hospital credentialing systems.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses hospital benefits records and insurance-claim trails that some physicians want to keep separate from credentialing.
- •Most physician-patients say what mattered most was: another physician at the same training level providing care; clear answer on board, DEA, and credentialing implications; same physician every visit; complete control over what their hospital and licensing board know.
The stressors specific to your work
- •Training trauma from residency hours, hierarchy, and unprocessed adverse clinical events
- •Perfectionism culture amplified by visible peer-review and morbidity-and-mortality processes
- •EHR burnout — clerical work crowding out clinical care and time at home
- •Malpractice anxiety creating chronic stress over decision-making
- •Identity-fusion with clinical role — difficulty separating "I made an error" from "I am bad"
- •Help-seeking suppressed by board-reporting and FSPHP-referral concerns, often based on misunderstanding of actual rules
Why telehealth works for physicians
- •No clinic visits — fits between hospital shifts, clinic, and call
- •Sessions scheduled evenings or weekends, no need to take time off
- •Treatment in your own home — no risk of being seen by colleagues, residents, or patients
- •Same physician every visit — continuity matters when bandwidth is scarce
- •Completely separate from hospital EAP, credentialing committee, or peer-review
Privacy considerations
- •Tovani is direct-pay — no insurance claim filed unless you submit for reimbursement yourself.
- •Patient records are HIPAA-protected and never shared with hospitals, state medical boards, DEA, FSPHP, credentialing committees, or any regulatory body without your explicit written authorization.
- •State medical board disclosure rules vary, but most jurisdictions only require disclosure of conditions that impair fitness to practice — NOT the existence of mental-health treatment itself. Well-managed outpatient depression or anxiety treatment is generally not reportable in most states. The Federation of State Medical Boards has explicitly encouraged states to remove broad mental-health-history questions; many states have already done so.
- •For physicians with prior FSPHP involvement or any current monitoring agreement, the calculus is different — consult a physician-attorney before starting treatment to understand your specific obligations.
- •For hospital credentialing, most institutions ask only about CURRENT conditions impairing practice. Routine outpatient mental-health care does not typically require disclosure.
DEA / licensure-sensitive role
Your profession has specific board-disclosure considerations. Discuss with your physician during consultation. For state-specific guidance, contact your state’s professional-assistance program.
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will my state medical board find out if I get ketamine therapy?
Not from Tovani. We don't report routine outpatient mental-health treatment to any state medical board, hospital credentialing committee, or FSPHP. Most state board disclosure questions ask about conditions that impair fitness to practice, NOT the existence of treatment. Well-managed outpatient depression or anxiety treatment is generally not reportable. The Federation of State Medical Boards has explicitly recommended states stop asking broad mental-health-history questions, and many have updated their applications accordingly.
What about my DEA registration?
Routine outpatient mental-health treatment that doesn't involve impaired-practice events or controlled-substance misuse is not a DEA-reportable event. The DEA cares about your ability to securely handle controlled substances and prescribe appropriately — receiving treatment for depression doesn't affect either. If you have specific concerns or a complicating history, consult a healthcare attorney before starting.
I'm worried about hospital credentialing and malpractice insurance applications.
Most credentialing applications and malpractice insurance forms ask about CURRENT conditions that impair practice, not treatment history. Well-managed outpatient depression or anxiety treatment is generally not a reportable item. For specific concerns about your hospital's application language or your malpractice carrier's questions, consult a physician-attorney before answering — but the vast majority of physicians on standard outpatient mental-health treatment do not need to disclose it.
I had a PHP / FSPHP referral years ago and got a clean release. Does that change things?
Yes, the calculus changes. If you have any past FSPHP involvement, current monitoring agreement, or prior board action, your disclosure obligations and reporting risk are different from a physician with no such history. Consult a physician-attorney familiar with your state's PHP rules before starting any new treatment. This is not a reason not to get treatment — but the process needs to be informed by your specific situation.
I'm a resident on multiple SSRIs without enough response. What about ketamine?
After two adequate SSRI trials without sufficient response, you meet the technical criteria for treatment-resistant depression. Ketamine's mechanism (NMDA receptor antagonism) is completely different from SSRIs, so prior failures don't predict ketamine response. Published response rates in treatment-resistant cases are 60-70%. Practical issue for residents: schedule sessions on a post-call or off day; you should not be on shift for 24 hours after a session.
References
- Zimmermann C et al. 2024, JAMA Psychiatry. Meta-analysis of physician suicide rates 1960-2024 — finds female physicians at elevated risk relative to the general female population and identifies ongoing need for stigma-free treatment pathways. PMID 39168499
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response in treatment-resistant depression — relevant for physicians who often have tried multiple SSRIs through their own prescribing knowledge or peer recommendations. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid antidepressant effects — particularly relevant for physician-patients with detailed clinical knowledge who want a different mechanism than serotonin-focused agents. PMID 28249076